Trade Bristol Myers BMY

Sell
 Buy

BristolMyers live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

BristolMyers News

Ava Grace 2025 Nov 08, 00:00

AI Funding Concerns Trigger Tech Stock Sell-Off

Sophia Claire 2025 Nov 08, 00:00

Gold Price Outlook: Currency Devaluation Trade Still Alive

Liam James 2025 Nov 08, 00:00

JPMorgan Sees Buying Opportunity Amid Market Jitters

Emma Rose 2025 Nov 07, 00:00

The Fed's Balance Sheet Expansion: Drivers and Potential Implications

Noah Lee 2025 Nov 07, 00:00

LME Aluminum Bull Run: Is a Structural Deficit Emerging?

Frances Wang 2025 Nov 06, 16:00

Gold and silver prices are up: what's happening to Gold (XAU/USD) and XAG?

Frances Wang 2025 Nov 06, 16:00

Nvidia Competitors Analysis (2026), NVDA Stock: AMD, Intel, Qualcomm, AVGO

Frances Wang 2025 Nov 05, 16:00

Crypto market update: Ethereum price drops, Bitcoin price falls below $104K

Frances Wang 2025 Nov 05, 16:00

XRP price prediction: XRP rebounds, Is XRP expected to go high?

Frances Wang 2025 Nov 05, 16:00

Tesla stock jumps 4% today: what’s driving the TSLA share price?

Latest news

Show more
Liam James 2025 Nov 09, 12:50

Ledger Eyes New York Listing as Crypto Thefts Surge

Emma Rose 2025 Nov 09, 12:10

Major Token Unlocks: LINEA, APT, AVAX Among Those Unlocking Next Week

Ava Grace 2025 Nov 09, 11:40

Crypto Market Updates: Key Events from November 10th to 16th

Ava Grace 2025 Nov 09, 11:30

LuBian Mining Pool Hack: A Technical Deep Dive into the $15 Billion Bitcoin Heist

Noah Lee 2025 Nov 09, 09:40

Robert Kiyosaki Doubles Down on Gold, Silver, Bitcoin, and Ethereum Amid Crash Fears

Sophia Claire 2025 Nov 09, 09:20

Macro Outlook, Crypto Updates, and Market Analysis: Insights from Financial Analysts

Sophia Claire 2025 Nov 09, 07:20

Ethereum Foundation's Evolving Funding Strategy: From Open Grants to Strategic Initiatives

Noah Lee 2025 Nov 09, 07:20

Italian Banks Endorse Digital Euro, Seek Cost Distribution

Info

Spread

0.29

Spread (%)

0.6225 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

14:31 - 20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Thursday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

95049310208

Shares Outstanding

2035753027

Earnings Date (Next)

2001-08-07

Div Yield

2025-11-03

Ex-Dividend Date

2025-10-03

Forward annual dividend rate

2.48

Forward annual dividend yield

0.0531

EPS

2.97

Learn more about this instrument

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel to treat patients with Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of relapsed/refractory multiple myeloma; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Reblozyl to treat anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Cobenfy to treat schizophrenia in adults; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; and Abraxane for the treatment of breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Ghko B 2025 Nov 06, 16:00

How to start cryptocurrency trading: how to trade BTC Price (BTC/USD) CFDs?

Ghko B 2025 Nov 06, 16:00

Xom Stock Forecast: What is the future forecast for XOM?

Ghko B 2025 Nov 06, 16:00

Top Australian Shares: Argo Investments, BHP, CBA stock and more

Trustpilot